XML 39 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Operating activities      
Net loss $ (11,721) $ (3,765) $ (11,497)
Adjustments to reconcile loss from continuing operations to net cash provided by (used in) operating activities:      
Net restructuring, severance and other charges (224) (333) 134
Net legal settlements 100 (185) 1,511
Impairments and other fair value adjustments 0 87 3,454
Loss on disposal of property & equipment 70 381 0
Depreciation 2,409 2,199 2,225
Amortization 1,392 1,243 3,461
Amortization of developed technology 8,012 1,022 1,294
Share-based compensation 2,427 3,405 3,140
Contingent consideration adjustment 0 93 (1,619)
Deferred income taxes 142 23 (371)
Change in cash surrender value of company owned life insurance policies (18) (564) (57)
Excess tax benefit from equity awards 0 0 (14)
Changes in operating assets and liabilities:      
Accounts receivable 6,372 3,237 (1,935)
Inventories 476 (2,051) (171)
Prepaid expense 1,946 (4,532) (526)
Accounts payable 554 (7,896) 5,528
Deferred revenue (4,034) 9,364 1,146
Accrued liabilities (4,250) 5,330 (3,868)
Income taxes receivable 45 16 (823)
Other changes, net (65) (226) (176)
Net cash provided by (used in) operating activities 3,433 7,218 (2,186)
Investing activities      
Proceeds from sale of business units 0 0 809
Cash paid for acquisitions, net 0 0 (3,750)
Investment in marketable securities 0 0 (10,240)
Proceeds from sale of marketable securities 0 0 10,107
Capital expenditures (4,158) (5,900) (4,650)
Capitalized software development costs (11,888) (15,048) (15,813)
Additional (investments in) proceeds from corporate-owned life insurance policies 2,181 (65) 1,905
Net cash used in investing activities (13,865) (21,013) (21,632)
Financing activities      
Principal payments under long-term obligations (117) (142) (144)
Exercise of employee stock options 0 0 102
Repurchase of common shares to satisfy employee tax withholding (533) (435) (373)
Excess tax benefit from equity awards 0 0 14
Net cash used in financing activities from continuing operations (847) (577) (401)
Payments to settle contingent consideration arising from business acquisitions (197) 0 0
Effect of exchange rate changes on cash (74) (87) (280)
Net decrease in cash and cash equivalents (11,353) (14,459) (24,499)
Cash and cash equivalents at beginning of period 60,608 75,067 99,566
Cash and cash equivalents at end of period $ 49,255 $ 60,608 $ 75,067